Table 1.
Baseline clinical and sociodemographic characteristics of the study group
| Variable | Values |
|---|---|
| Age [years] (M ± SD) | 36.7 ± 9.56 |
| Sex, n (%) | |
| Female | 101 (100) |
| Male | 0 (0) |
| Clinical type of MS n (%) | |
| RRMS | 82 (81.1%) |
| SPMS | 14 (13.9%) |
| PPMS | 5 (5.0%) |
| PRMS | 0 (0%) |
| Disease duration in months (M ± SD) | 75.1 ± 50.2 |
| Number of relapses in the past (M ± SD) | 1.2 ± 0.8 |
| Time since a most recent relapse in months (M ± SD) | 3.1 ± 1.23 |
| Education level, n (%) | |
| Basic or vocational education | 8 (7.83) |
| Secondary education | 38 (37.62) |
| Higher education | 55 (54.46) |
| Place of residence, n (%) | |
| Village | 19 (18.81) |
| City | 82 (81.19) |
| Marital status, n (%) | |
| Single | 35 (34.65) |
| Married | 58 (57.43) |
| Widowed | 1 (0.99) |
| Divorced | 7 (6.93) |
| Professional activity n (%) | |
| Employed | 66 (65.35) |
| Unemployed | 13 (12.87) |
| Disability pension/Retirement pension | 22 (21.78) |
| SSQ score (M ± SD) | 29.1 ± 6.4 |
| FSFI score (M ± SD) | 26.53 ± 6.97 |
| SWLS score (M ± SD) | 15.95 ± 6.27 |
| MusiQOL score (M ± SD) | 60.89 ± 14.16 |
DMT = disease modifying therapy; FSFI = Female Sexual Function Index; M = mean; MS = multiple sclerosis; MusiQOL = Multiple Sclerosis International Quality of Life Questionnaire; PPMS = primary progressive MS; PRMS = primary progressive MS; RRMS = relapsing remitting MS; SD = standard deviation; SPMS = secondary progressive MS; SSQ = Sexual Satisfaction Questionnaire; SWLS = Satisfaction with Life Scale.